Plunkett Research Online: Vical Incorporated

VICAL INCORPORATED (VICL:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Vical Incorporated researches and develops biopharmaceutical products, including those based on its patented DNA delivery technologies, for the prevention and treatment of serious or life-threatening diseases. The company’s research areas include vaccines for use in high-risk populations for infect.....



Vical Incorporated
Ticker: VICL
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 858 646-1100
Fax: 858 646-1150
Address: 10390 Pacific Center Court
San Diego, CA 92121-4340 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Drug Delivery Systems
Cancer, Infectious Disease & Metabolic Disease Drugs & Vaccines
ContactsDescription
Vijay SamantCEO/Director/President
Anthony RamosCFO/Chief Accounting Officer/Vice President
See More
Vical Incorporated researches and develops biopharmaceutical products, including those based on its patented DNA delivery technologies, for the prevention and treatment of serious or life-threatening diseases. The company’s research areas include vaccines for use in high-risk populations for infect.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor: Cooley LLP
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
HSV-2
VL-2397
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: